Literature DB >> 3169233

Inhibition of HIV replication by amino-sugar derivatives.

G W Fleet1, A Karpas, R A Dwek, L E Fellows, A S Tyms, S Petursson, S K Namgoong, N G Ramsden, P W Smith, J C Son.   

Abstract

The plant alkaloids castanospermine, dihydroxymethyldihydroxypyrrolidine and deoxynojirimycin have recently been shown to have potential anti-HIV activity [(1987) Proc. Natl. Acad. Sci. USA 84, 8120-8124; (1987) Nature 330, 74-77; (1987) Lancet i, 1025-1026]. They are thought to act by inhibiting alpha-glucosidase I, an enzyme involved in the processing of N-linked oligosaccharides on glycoproteins. We report here the relative efficacy of a spectrum of amino-sugar derivatives as inhibition of HIV cytopathicity. Several alpha-glucosidase inhibitors and alpha-fucosidase inhibitors were found to be active at concentrations which were non-cytotoxic.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169233     DOI: 10.1016/0014-5793(88)80185-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16.

Authors:  Katie J Doores; Dennis R Burton
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  Identification of the genes involved in 1-deoxynojirimycin synthesis in Bacillus subtilis MORI 3K-85.

Authors:  Kyung-Don Kang; Yong Seok Cho; Ji Hye Song; Young Shik Park; Jae Yeon Lee; Kyo Yeol Hwang; Sang Ki Rhee; Ji Hyung Chung; Ohsuk Kwon; Su-Il Seong
Journal:  J Microbiol       Date:  2011-06-30       Impact factor: 3.422

3.  Inhibition of alpha-L-fucosidase by derivatives of deoxyfuconojirimycin and deoxymannojirimycin.

Authors:  B Winchester; C Barker; S Baines; G S Jacob; S K Namgoong; G Fleet
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

4.  Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.

Authors:  D Durantel; N Branza-Nichita; S Carrouée-Durantel; T D Butters; R A Dwek; N Zitzmann
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Aminosugar derivatives as potential anti-human immunodeficiency virus agents.

Authors:  A Karpas; G W Fleet; R A Dwek; S Petursson; S K Namgoong; N G Ramsden; G S Jacob; T W Rademacher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Authors:  P B Fischer; M Collin; G B Karlsson; W James; T D Butters; S J Davis; S Gordon; R A Dwek; F M Platt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 7.  Anti-AIDS drug development: challenges and strategies.

Authors:  P Mohan
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

8.  Inhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cells.

Authors:  D L Taylor; M S Kang; T M Brennan; C G Bridges; P S Sunkara; A S Tyms
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

9.  N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.

Authors:  P B Fischer; G B Karlsson; T D Butters; R A Dwek; F M Platt
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.

Authors:  P B Fischer; G B Karlsson; R A Dwek; F M Platt
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.